What is the current valuation of the US carotid artery-disease market?

The market valuation was $2630.0 Million in 2024. Read More

What is the projected market size for the US carotid artery-disease market by 2035?

The market is expected to reach $4360.0 Million by 2035. Read More

What is the expected CAGR for the US carotid artery-disease market during the forecast period 2025 - 2035?

The expected CAGR is 4.7% during the forecast period. Read More

Which companies are the key players in the US carotid artery-disease market?

Key players include Medtronic, Abbott Laboratories, Boston Scientific, and Johnson & Johnson. Read More

What are the main segments of the US carotid artery-disease market?

The main segments include Type, Diagnosis, Medications, Surgical Procedures, and End-User. Read More

What was the valuation of the surgical procedures segment in 2024?

The surgical procedures segment was valued at $2630.0 Million in 2024. Read More

How much is the medication segment projected to be worth by 2035?

The medication segment is projected to be worth between $1200.0 Million and $1800.0 Million by 2035. Read More

What is the valuation range for duplex ultrasound in the diagnosis segment?

The valuation range for duplex ultrasound is between $790.0 Million and $1300.0 Million. Read More

What are the expected valuations for the end-user segment in 2025?

The end-user segment is expected to range from $780.0 Million to $1750.0 Million. Read More

Which surgical procedure segment has the highest valuation in 2024?

Carotid endarterectomy had the highest valuation at $1630.0 Million in 2024. Read More

US Carotid Artery Disease Market

ID: MRFR/MED/11607-HCR

100 Pages

Satyendra Maurya

Last Updated: May 13, 2026

US Carotid Artery Disease Market Research Report: By Diagnosis & Treatment (Carotid Artery Disease, Antihypertensive Drugs) and By End User (Hospital & Clinics, Ambulatory Surgical Centers, Pharmacies) - Growth & Industry Forecast 2025 To 2035

US Carotid Artery Disease Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.7%

2024 Market Size$ 2,630 Million

2025 Market Size$ 2,753.61 Million

2035 Market Size$ 4,360 Million

Key Players

Medtronic

Abbott Laboratories

Boston Scientific

Johnson & Johnson

B. Braun Melsungen AG

Terumo Corporation

Trends

Technological Advancements in Treatment
Increased Awareness and Screening
Regulatory Support for Innovation

Opportunities

Increased Focus on Preventive Healthcare
Rising Incidence of Carotid Artery Disease
Advancements in Medical Imaging Technologies

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Security, Access Control and Robotics, BY Type (USD Million) | |
  1. 4.1.1 Surgery | |
  2. 4.1.2 Medication | |
  3. 4.1.3 Diagnosis |
2. 4.2 Security, Access Control and Robotics, BY Diagnosis (USD Million) | |
  1. 4.2.1 Duplex Ultrasound | |
  2. 4.2.2 Compound Tomography | |
  3. 4.2.3 Magnetic Resonance Imaging | |
  4. 4.2.4 Others |
3. 4.3 Security, Access Control and Robotics, BY Medications (USD Million) | |
  1. 4.3.1 Antiplatelet Drugs | |
  2. 4.3.2 Cholesterol-Lowering Statins | |
  3. 4.3.3 Antihypertensive Drugs |
4. 4.4 Security, Access Control and Robotics, BY Surgical Procedures (USD Million) | |
  1. 4.4.1 Carotid Artery Angioplasty | |
  2. 4.4.2 Carotid Artery Bypass | |
  3. 4.4.3 Carotid Endarterectomy |
5. 4.5 Security, Access Control and Robotics, BY End-User (USD Million) | |
  1. 4.5.1 Clinics and Hospitals | |
  2. 4.5.2 Pharmacies | |
  3. 4.5.3 Ambulatory Surgical Centres 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Medtronic (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Abbott Laboratories (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Boston Scientific (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Johnson & Johnson (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 B. Braun Melsungen AG (DE) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Terumo Corporation (JP) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Stryker Corporation (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Cook Medical (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Cardinal Health (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 US MARKET ANALYSIS BY TYPE |
6. 6.3 US MARKET ANALYSIS BY DIAGNOSIS |
7. 6.4 US MARKET ANALYSIS BY MEDICATIONS |
8. 6.5 US MARKET ANALYSIS BY SURGICAL PROCEDURES |
9. 6.6 US MARKET ANALYSIS BY END-USER |
10. 6.7 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS |
11. 6.8 RESEARCH PROCESS OF MRFR |
12. 6.9 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS |
13. 6.10 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS |
14. 6.11 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS |
15. 6.12 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS |
16. 6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TYPE, 2024 (% SHARE) |
17. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TYPE, 2024 TO 2035 (USD Million) |
18. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DIAGNOSIS, 2024 (% SHARE) |
19. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DIAGNOSIS, 2024 TO 2035 (USD Million) |
20. 6.17 SECURITY, ACCESS CONTROL AND ROBOTICS, BY MEDICATIONS, 2024 (% SHARE) |
21. 6.18 SECURITY, ACCESS CONTROL AND ROBOTICS, BY MEDICATIONS, 2024 TO 2035 (USD Million) |
22. 6.19 SECURITY, ACCESS CONTROL AND ROBOTICS, BY SURGICAL PROCEDURES, 2024 (% SHARE) |
23. 6.20 SECURITY, ACCESS CONTROL AND ROBOTICS, BY SURGICAL PROCEDURES, 2024 TO 2035 (USD Million) |
24. 6.21 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END-USER, 2024 (% SHARE) |
25. 6.22 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END-USER, 2024 TO 2035 (USD Million) |
26. 6.23 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
27. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
28. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million) | |
  3. 7.2.3 BY MEDICATIONS, 2025-2035 (USD Million) | |
  4. 7.2.4 BY SURGICAL PROCEDURES, 2025-2035 (USD Million) | |
  5. 7.2.5 BY END-USER, 2025-2035 (USD Million) |
29. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
30. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

US Carotid Artery Disease Market Segmentation

US Carotid Artery Disease Market By Type (USD Million, 2025-2035)

Surgery
Medication
Diagnosis

US Carotid Artery Disease Market By Diagnosis (USD Million, 2025-2035)

Duplex Ultrasound
Compound Tomography
Magnetic Resonance Imaging
Others

US Carotid Artery Disease Market By Medications (USD Million, 2025-2035)

Antiplatelet Drugs
Cholesterol-Lowering Statins
Antihypertensive Drugs

US Carotid Artery Disease Market By Surgical Procedures (USD Million, 2025-2035)

Carotid Artery Angioplasty
Carotid Artery Bypass
Carotid Endarterectomy

US Carotid Artery Disease Market By End-User (USD Million, 2025-2035)

Clinics and Hospitals
Pharmacies
Ambulatory Surgical Centres

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”